右盐酸芬氟拉明

右盐酸芬氟拉明结构式
右盐酸芬氟拉明结构式
品牌特惠专场
常用名 右盐酸芬氟拉明 英文名 (S)-fenfluramine hydrochloride
CAS号 3239-45-0 分子量 267.71800
密度 N/A 沸点 243.1ºC at 760mmHg
分子式 C12H17ClF3N 熔点 159-163ºC
MSDS 中文版 美版 闪点 100.8ºC
符号 GHS06
GHS06
信号词 Danger

Pulmonary hypertension and the serotonin hypothesis: where are we now?

Int. J. Clin. Pract. Suppl. (156) , 27-31, (2007)

In the 1960s, serotonin (5HT) was associated with pulmonary arterial hypertension (PAH) caused by certain diet pills, but has recently been the subject of renewed interest in the field of PAH. Serotonin can be synthesised in the pulmonary endothelium with the...

O2 reduction by a functional heme/nonheme bis-iron NOR model complex.

Proc. Natl. Acad. Sci. U. S. A. 106(26) , 10528-33, (2009)

O(2) reactivity of a functional NOR model is investigated by using electrochemistry and spectroscopy. The electrochemical measurements using interdigitated electrodes show very high selectivity for 4e O(2) reduction with minimal production of partially reduce...

Ribonuclease S redux.

Chem. Commun. (Camb.) 47(3) , 973-5, (2011)

The S-peptide and S-protein components of bovine pancreatic ribonuclease form a noncovalent complex with restored ribonucleolytic activity. Although this archetypal protein-fragment complementation system has been the object of historic work in protein chemis...

A novel procedure for assessing the effects of drugs on satiation in baboons: effects of memantine and dexfenfluramine.

Psychopharmacology 199(4) , 583-92, (2008)

Procedures for studying the effects of medications on satiation will assist the development of obesity medications.Develop a procedure for measuring satiation during consumption of bland and highly palatable food and determine the effect of acute intramuscula...

Consumption of palatable food decreases the anorectic effects of serotonergic, but not dopaminergic drugs in baboons

Physiol. Behav. 103(5) , 493-500, (2011)

We examined the effects of periodic access to a palatable, high sugar content food (candy) in 8 male baboons on the anorectic response to d-amphetamine, which increases dopamine, and dexfenfluramine, which increases serotonin. During candy access, up to 200 c...

Characterization of a novel and selective cannabinoid CB1 receptor inverse agonist, Imidazole 24b, in rodents.

Eur. J. Pharmacol. 579(1-3) , 215-24, (2008)

We document in vitro and in vivo effects of a novel, selective cannabinoid CB(1) receptor inverse agonist, Imidazole 24b (5-(4-chlorophenyl)-N-cyclohexyl-4-(2,4-dichlorophenyl)-1-methyl-imidazole-2-carboxamide). The in vitro binding affinity of Imidazole 24b ...

Hypothalamic neuropeptide Y (NPY) gene expression is not affected by central serotonin in the rainbow trout (Oncorhynchus mykiss).

Comp. Biochem. Physiol. A. Mol. Integr. Physiol. 166(1) , 186-90, (2013)

Mammalian studies have shown a link between serotonin (5-HT) and neuropeptide Y (NPY) in the acute regulation of feeding and energy homeostasis. Taking into account that the actions of 5-HT and NPY on food intake in fish are similar to those observed in mamma...

Dexfenfluramine discontinuous treatment does not worsen hypoxia-induced pulmonary vascular remodeling but activates RhoA/ROCK pathway: consequences on pulmonary hypertension.

Eur. J. Pharmacol. 602(2-3) , 355-63, (2009)

The anorectic drug, dexfenfluramine has been associated with an increase in the relative risk of developing pulmonary hypertension. 5-hydroxytryptamine (5-HT) is a mitogen for smooth muscle cell, an effect that relies on 5-HT transporter expression and which ...

Effects of acute administration of phentermine, alone or in combination with dexfenfluramine, on pain reactivity in the adult rat.

Pharmacol. Biochem. Behav. 90(3) , 339-43, (2008)

In the 1990s, phentermine was combined with either fenfluramine or its active enantiomer dexfenfluramine to promote weight loss. Appetite suppressants are known to alter pain reactivity. The current experiment examined the acute impact of phentermine (0, 2.5,...

End of the line for cannabinoid receptor 1 as an anti-obesity target?

Nat. Rev. Drug Discov. 7(12) , 961-2, (2008)

A wave of terminations of development programmes for cannabinoid receptor 1 blockers for obesity indicates the demise of a drug class that was once anticipated to yield blockbusters. Nevertheless, lessons learned might help salvage something for future such a...